Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers April 22, 2018
Pharmacy Choice - News - Generic Drugs - April 22, 2018

Pharmacy News

 Generic Drugs
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 59     Next >>     Go To Page:

4/21/18 - Anger against PM Modi's remarks in UK on Indian doctors not prescribing generic drugs [New Indian Express (India)]
NEW DELHI: Doctors from several parts of the country have said that PM Modi's "unjust" and "uncalled for" remarks in the UK on most doctors in India not prescribing generic drugs and getting sponsorships from pharmaceutical companies for foreign trips have "humiliated" them. "Your comments on us in the UK is a big setback for medical tourism in In
4/21/18 - Celltrion`s Truxima approved in Australia [Arab Finance (Egypt)]
South Korean biopharmaceutical firm Celltrion Inc. said Friday it has won an approval from an Australian regulator for the sale of its biosimilar drug Truxima. The Therapeutic Goods Administration accepted Celltrion`s application to sell the biosimilar to Roche`s Mabthera, the company said. The antibody biosimilar is used in the treatment of a numb
4/21/18 - Rep. Maloney Calls for Hearing Into Anti-Competitive Practices in Prescription Drug Market
Congresswoman Carolyn B. Maloney sent a letter Thursday formally requesting that the Joint Economic Committee hold a hearing anti-competitive practices in the prescription drug market. In her letter the Congresswoman noted that " the United States pays more than $1,000 per person on prescription drugs, which is the highest per-capita cost in the wo
4/21/18 - US Food and Drug Administration Now Approves Distribution of Suboxones Generic Version in the USA [Saudi Gazette, The]
-Heroin Detox Clinics completes guide to Suboxone and questions related to the drug in new post. The US Food and Drug Administration recently approved the manufacturing and distribution of the generic version of Suboxone in the American market. One of the most prevalent issues in many developed nations including the United States is opioid...
4/20/18 - Findings from University of Pisa Broaden Understanding of Rare Diseases and Conditions (Generic Substitution of Orphan Drugs for the Treatment of...
Findings from University of Pisa Broaden Understanding of Rare Diseases and Conditions. According to news originating from Pisa, Italy, by NewsRx correspondents, research stated, "Generic drugs are important components of measures introduced by healthcare regulatory authorities to reduce treatment costs. Our news journalists obtained a quote from t
4/20/18 - Intellipharmaceutics Announces First Quarter 2018 Results
TORONTO, ON/ ACCESSWIRE/ April 16, 2018/ Intellipharmaceutics International Inc., a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs, today reported the results of operations for the three months ended February 28, 2018.
4/20/18 - New Findings on Growth Hormones Reported by I. Marciano et al (Pattern of Use of Biosimilar and Originator Somatropin in Italy: A Population-Based...
By a News Reporter-Staff News Editor at Drug Week New research on Drugs and Therapies- Growth Hormones is the subject of a report. According to news reporting out of Messina, Italy, by NewsRx editors, research stated, "Somatropin is approved in children and adults for several conditions involving growth disturbances and the corresponding biosimil
4/20/18 - Reports Summarize Coagulation Modifiers Study Results from J. Martinez Gonzalez and Co-Researchers (Bioequivalence of a biosimilar enoxaparin sodium...
Reports Summarize Coagulation Modifiers Study Results from J. Martinez Gonzalez and Co-Researchers. By a News Reporter-Staff News Editor at Drug Week A new study on Drugs and Therapies- Coagulation Modifiers is now available. According to news reporting originating from Madrid, Spain, by NewsRx correspondents, research stated, "To demonstrate the
4/20/18 - Reps. Mullin, Schrader Introduce Reauthorization of Animal Drug User Fee Act
Markwayne Mullin, R- Oklahoma, issued the following news release:. Congressman Markwayne Mullin and Congressman Kurt Schrader introduced H.R. 5554 to reauthorize the Food and Drug Administration's Animal Drug User Fee Act and Animal Generic Drug User Fee Act. ADUFA/AGDUFA would continue agreements between the FDA and the animal drug industry to pay
4/20/18 - Reps. Schrader, Mullin Introduce Bipartisan Reauthorization of Animal Drug User Fee Act
Kurt Schrader, D- Oregon, issued the following news release:. Congressman Kurt Schrader and Congressman Markwayne Mullin and introduced H.R. 5554 to reauthorize the Food and Drug Administration's Animal Drug User Fee Act and Animal Generic Drug User Fee Act. ADUFA and AGDUFA would continue agreements between the FDA and the animal drug industry to
4/20/18 - Supply Generic Drugs
Company: BAC LIEU GENERAL HOSPITAL. Address: Bac Lieu General Hospital- 06 Nguyen Hue Street, Ward 3, Bac Lieu Province, Bac Lieu Province. Description: Tenders are invited for Supply Generic Drugs Medication by generic name Bidding forms: Domestic competitive offer Selling prices HS: 1.000. 000 ng.
4/20/18 - US Food and Drug Administration Now Approves Distribution of Suboxone's Generic Version in the USA
Heroin Detox Clinics completes guide to Suboxone and questions related to the drug in new post. The US Food and Drug Administration recently approved the manufacturing and distribution of the generic version of Suboxone in the American market. One of the most prevalent issues in many developed nations including the United States is opioid depende
4/19/18 - Deal protects worlds biggest selling drug from biosimilar erosion [All Iraq News Agency (AIN)]
AbbVie and Samsung Bioepis resolve patent litigation over arthritis drug Humira. AbbVie has settled a legal case with biosimilars company Samsung Bioepis over Imraldi, the South Korean companys proposed version of AbbVies blockbuster TNF inhibitor Humira. Last September, AbbVie settled a similar case with Amgen, and its Humira biosimilar, Amjevita,
4/19/18 - Eagle Pharmaceuticals' Vasopressin ANDA Accepted for Filing by the FDA
WOODCLIFF LAKE- Eagle Pharmaceuticals, Inc. today announced that it has submitted and the U.S. Food and Drug Administration has accepted for filing its abbreviated new drug application for vasopressin injection, 1 ml. 'We are pleased that the FDA has accepted our vasopressin injection formulation for filing. We look forward to the FDA's decision an
4/19/18 - FDA Commissioner Gottlieb Issues Remarks Before House Subcommittee on Agriculture
I'd like to thank the Committee for your commitment to FDA. Last year was a record year for medical products at FDA; with the most ever approvals of generic drugs, novel drugs and medical devices. FDA is committed to these and other public health goals.
4/19/18 - Four Canadian provinces add ErelziTM (etanercept) to provincial drug plans for the treatment of multiple inflammatory diseases
-Manitoba, Saskatchewan, Alberta and Newfoundland are the most recent provinces to add Sandoz biosimilar Erelzi to provincial drug plans for the treatment of multiple inflammatory diseases. The provincial listings respectively became effective on April 19 in Manitoba, April 1, 2018 in Saskatchewan, Newfoundland and on March 1, 2018 in Alberta.
4/19/18 - Heritage Pharma Announces Executive Leadership Changes
Heritage Pharmaceuticals, a generic pharmaceuticals company, issued the following news release:. Heritage Pharmaceuticals Inc., an East Brunswick- based specialty generic pharmaceutical company, today announced that industry veteran William S. Marth has joined the Company as President and Chief Executive Officer, North America and Europe, of the...
4/19/18 - Pharmaceutical Excipients (Organic chemical (Carbohydrate, Petrochemical), Inorganic chemical) Market - Global Forecast to 2023
The "Pharmaceutical Excipients Market by Type, Functionality, Formulation- Global Forecast to 2023" report has been added to ResearchAndMarkets.com' s offering. The pharmaceutical excipients market is expected to reach USD 8.53 billion by 2023 from USD 6.40 billion in 2018, at a CAGR of 5.9%. The overall growth of the pharmaceutical excipients mark
4/19/18 - Pharmaceutical Excipients (Organic chemical (Carbohydrate, Petrochemical), Inorganic chemical) Market - Global Forecast to 2023 - ResearchAndMarkets.com
The "Pharmaceutical Excipients Market by Type, Functionality, Formulation- Global Forecast to 2023" report has been added to ResearchAndMarkets.com' s offering. The pharmaceutical excipients market is expected to reach USD 8.53 billion by 2023 from USD 6.40 billion in 2018, at a CAGR of 5.9%. The overall growth of the pharmaceutical excipients mark
4/18/18 - Advent in direct talks to buy Sanofi's generics arm Zentiva
French pharmaceutical group Sanofi has entered exclusive talks with the US private equity company Advent International to sell its the Europe generic drugs branch Zentiva for CZK48bn, the companies stated on April 17. Zentiva has a seat in Prague and is present in more than 50 markets. According to the news agency, the planned sale of Zentiva began
4/18/18 - ANI Pharma Announces Approval Of Morphine Sulfate Oral Solution
WASHINGTON- ANI Pharmaceuticals Inc. said that it has received approval from the U.S. Food and Drug Administration of its Abbreviated New Drug Application or "ANDA" for Morphine Sulfate Oral Solution 10 mg/5mL, 20 mg/5mL and 100 mg/5mL. The current annual U.S. market for this product is approximately $17 million, according to Iqvia/IMS Health.
4/18/18 - ANI Pharmaceuticals Announces Approval of Morphine Sulfate Oral Solution
ANI Pharmaceuticals, Inc. today announced that it has received approval from the U.S. Food and Drug Administration of its Abbreviated New Drug Application for Morphine Sulfate Oral Solution 10 mg/5mL, 20 mg/5mL and 100 mg/5mL. The current annual U.S. market for this product is approximately $17 million, according to Iqvia/IMS Health. ANI Pharmace
4/18/18 - Cambrex Invests in New Continuous Flow Technology at its High Point, NC Facility [Daily Independent (Nigeria)]
-Cambrex Corporation, the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients, today announced that it has completed the installation of multiple continuous flow reactor platforms at its High Point, NC facility. Shawn Conway, who has joined Cambrex as Director of Engineering R&D. We are seeing significant.
4/18/18 - China strengthens IP protection for innovative drugs
The China State Council declared that "innovative drugs" will be afforded up to a six-year data exclusivity period from the date of marketing authorization, during which generic versions will not enter the market. The protection prevents generic manufacturers from referring to CMC data in the original drug application to establish equivalence, acco
4/18/18 - FDA Finalizes Special Protocol Assessment Guidance for Industry [Syrian Arab News Agency]
The FDA has finalized its guidance on the Center for Drug Evaluation and Research and the Center for Biologics Evaluation and Research special protocol assessments. An SPA agreement indicates that the FDA concurs with the adequacy and acceptability of the overall protocol design, though it does not guarantee that the FDA will accept a New Drug Appl
Articles(s): 1 - 25 of 59     Next >>     Go To Page:


© 2018 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2018 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415